Progesterone-receptor index in meningiomas: Correlation with clinico-pathological parameters and review of the literature

Neurosurgical Review

Volumn 27, Issue 4, 2004, Pages 238-245

  Wolfsberger, Stefan ^a,b   Doostkam, Soroush ^c   Boecher Schwarz, Hans Gerd ^c   Roessler, Karl ^a   Van Trotsenburg, Michael ^a   Hainfellner, Johannes A ^b   Knosp, Engelbert ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Clinico pathological study; Meningioma; MIB 1; Progesterone receptor; Proliferation marker

Indexed keywords

ANTIGESTAGEN; KI 67 ANTIGEN; MONOCLONAL ANTIBODY KI 67; PROGESTERONE RECEPTOR;

ADULT; AGED; CANCER HORMONE THERAPY; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SEX RATIO; TUMOR RECURRENCE;

ADULT; AGE FACTORS; AGED; FEMALE; HUMANS; KI-67 ANTIGEN; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RECEPTORS, PROGESTERONE; SEX FACTORS;

EID: 5344225266     PISSN: 03445607     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10143-004-0340-y     Document Type: Review

References (66)

1. Aziz DC (1992) Quantitation of estrogen and progesterone receptors by immunocytochemical and image analyses. Am J Clin Pathol 98:105-111
2. Bickerstaff ER, Small JM, Guest IA (1958) The relapsing course of certain meningiomas in relation to pregnancy and menstruation. J Neurochem 21:89-91
3. Blaauw G, Blankenstein MA, Lamberts SW (1986) Sex steroid receptors in human meningiomas. Acta Neurochir (Wien) 79:42-47
4. Blaauw G, Koudstaal J, Blankenstein MA, Debets-Te BM, Gijzen AH (1995) Progestin receptors in meningiomas. Comparison of cytosolic assays with immunocytochemical identification in cryostat and paraffin sections. Acta Neurochir (Wien) 134:83-87
5. Black PM (1993) Meningiomas. Neurosurgery 32:643-657
6. Black P, Carroll R, Zhang J (1996) The molecular biology of hormone and growth factor receptors in meningiomas. Acta Neurochir Suppl (Wien) 65:50-53
7. Blankenstein MA, Meulen-Dijk C, Thijssen JH (1989) Effect of steroids and antisteroids on human meningioma cells in primary culture. J Steroid Biochem 34:419-421
8. Blankenstein MA, Verheijen FM, Jacobs JM, Donker TH, van Duijnhoven MW, Thijssen JH (2000) Occurrence, regulation, and significance of progesterone receptors in human meningioma. Steroids 65:795-800
9. Bouillot P, Pellissier JF, Devictor B, Graziani N, Bianco N, Grisoli F, Figarella-Branger D (1994) Quantitative imaging of estrogen and progesterone receptors, estrogen-regulated protein, and growth fraction: immunocytochemical assays in 52 meningiomas. Correlation with clinical and morphological data. J Neurosurg 81:765-773
10. Bozzetti C, Camisa R, Nizzoli R, Manotti L, Guazzi A, Naldi N, Mazza S, Nizzoli V, Cocconi G (1995) Estrogen and progesterone receptors in human meningiomas: biochemical and immunocytochemical evaluation. Surg Neurol 43:230-233
11. Brandis A, Mirzai S, Tatagiba M, Walter GF, Samii M, Ostertag H (1993) Immunohistochemical detection of female sex hormone receptors in meningiomas: correlation with clinical and histological features. Neurosurgery 33:212-217
12. Carroll RS, Glowacka D, Dashner K, Black PM (1993) Progesterone receptor expression in meningiomas. Cancer Res 53:1312-1316
13. Carroll RS, Zhang J, Dashner K, Black PM (1995) Progesterone and glucocorticoid receptor activation in meningiomas. Neurosurgery 37:92-97
14. Carroll RS, Zhang J, Black PM (1999) Expression of estrogen receptors alpha and beta in human meningiomas. J Neurooncol 42:109-116
15. Carroll RS, Brown M, Zhang J, DiRenzo J, De Mora JF, Black PM (2000) Expression of a subset of steroid receptor cofactors is associated with progesterone receptor expression in meningiomas. Clin Cancer Res 6:3570-3575
16. Davis C (1995) Surgical and non-surgical treatment of symptomatic intracranial meningiomas. Br J Neurosurg 9:295-302
17. Donnell MS, Meyer GA, Donegan WL (1979) Estrogen-receptor protein in intracranial meningiomas. J Neurosurg 50:499-502
18. Fewings PE, Battersby RD, Timperley WR (2000) Long-term follow up of progesterone receptor status in benign meningioma: a prognostic indicator of recurrence? J Neurosurg 92:401-405
19. Georgakulias N, Singounas E, Kypriades E, Giotis J, Karvounis P (1993) Estrogen and progesterone receptors in meningiomas and gliomas. Zentralbl Neurochir 54:139-142
20. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133:1710-1715
21. Grunberg SM (1991) The role of progesterone receptors in meningioma. Cancer Treat Res 58:127-137
22. Grunberg SM, for the Southwest and Eastern Cooperative Oncology Group (2001) Phase III double-blind randomized placebo-controlled study of mifepristone for the treatment of unresectable meningioma. Proc ASCO 20:56a
23. Grunberg SM, Weiss MH, Spitz IM, Ahmadi J, Sadun A, Russell CA, Lucci L, Stevenson LL (1991) Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone. J Neurosurg 74:861-866
24. Gursan N, Gundogdu C, Albayrak A, Kabalar ME (2002) Immunohistochemical detection of progesterone receptors and the correlation with Ki-67 labeling indices in paraffin-embedded sections of meningiomas. Int J Neurosci 112:463-470
25. Haak HR, de Keizer RJ, Hagenouw-Taal JC, van Seters AP, Vielvoye GJ, van Dulken H (1990) Successful mifepristone treatment of recurrent, inoperable meningioma. Lancet 336:124-125
26. Halper J, Colvard DS, Scheithauer BW, Jiang NS, Press MF, Graham ML, Riehl E, Laws ER Jr, Spelsberg TC (1989) Estrogen and progesterone receptors in meningiomas: comparison of nuclear binding, dextran-coated charcoal, and immunoperoxidase staining assays. Neurosurgery 25:546-552
27. Hayward E, Whitwell H, Paul KS, Barnes DM (1984) Steroid receptors in human meningioma. Clin Neuropharmacol 7:351-356
28. Hilbig A, Barbosa-Coutinho LM (1998) Meningiomas and hormonal receptors. Immunohistochemical study in typical and non-typical tumors. Arq Neuropsiquiatr 56:193-199
29. Ho DM, Hsu CY, Ting LT, Chiang H (2002) Histopathology and MIB-1 labeling index predicted recurrence of meningiomas: a proposal of diagnostic criteria for patients with atypical meningioma. Cancer 94:1538-1547
30. Hsu DW, Efird JT, Hedley-Whyte ET (1997) Progesterone and estrogen receptors in meningiomas: prognostic considerations. J Neurosurg 86:113-120
31. Hsu DW, Efird JT, Hedley-Whyte ET (1998) MIB-1 (Ki-67) index and transforming growth factor-alpha (TGF alpha) immunoreactivity are significant prognostic predictors for meningiomas. Neuropathol Appl Neurobiol 24:441-452
32. Jay JR, MacLaughlin DT, Riley KR, Martuza RL (1985) Modulation of meningioma cell growth by sex steroid hormones in vitro. J Neurosurg 62:757-762
33. Keppes JJ (1982) Meningiomas: biology, pathology and differential diagnosis. Masson, New York, p 206ff
34. Khalid H (1994) Immunohistochemical study of estrogen receptor-related antigen, progesterone and estrogen receptors in human intracranial meningiomas. Cancer 74:679-685
35. Koehorst SG, Spapens ME, Van Der Kallen CJ, Van'T V, Blaauw G, Thijssen JH, Blankenstein MA (1998) Progesterone receptor synthesis in human meningiomas: relation to the estrogen-induced proteins pS2 and cathepsin-D and influence of epidermal growth factor, forskolin and phorbol ester in vitro. Int J Biol Markers 13:16-23
36. Koper JW, Lamberts SW (1994) Meningiomas, epidermal growth factor and progesterone. Hum Reprod 9 (Suppl 1):190-194
37. Kostron H, Daxenbichler G, Maier H (1990) Steroid receptors and atypical histology as prognostic parameters in meningioma. Wien Klin Wochenschr 102:525-528
38. Kuratsu JI, Seto H, Kochi M, Ushio Y (1994) Expression of PDGF, PDGF-receptor, EGF-receptor and sex hormone receptors on meningioma. Acta Neurochir (Wien) 131:289-293
39. Lamberts SW, Tanghe HL, Avezaat CJ, Braakman R, Wijngaarde R, Koper JW, de Jong H (1992) Mifepristone (RU 486) treatment of meningiomas. J Neurol Neurosurg Psychiatry 55:486-490
40. Lieu AS, Hwang SL, Howng SL (2003) Intracranial meningioma and breast cancer. J Clin Neurosci 10:553-556
41. Louis DN, Scheithauer BW, Budka H (2000) Meningiomas. In: Kleihues P et al (eds) WHO classification of tumors: pathology and genetics of tumours of the nervous system. IARC, Lyon, pp 176-184
42. Mahmood A, Caccamo DV, Tomecek FJ, Malik GM (1993) Atypical and malignant meningiomas: a clinicopathological review. Neurosurgery 33:955-963
43. Maiuri F, Montagnani S, Gallicchio B, Carandente M, Lanza GG, D'Andrea F (1989) Oestrogen and progesterone sensitivity in cultured meningioma cells. Neurol Res 11:9-13
44. Marks SM, Whitwell HL, Lye RH (1986) Recurrence of meningiomas after operation. Surg Neurol 25:436-440
45. Markwalder TM, Zava DT, Goldhirsch A, Markwalder RV (1983) Estrogen and progesterone receptors in meningiomas in relation to clinical and pathologic features. Surg Neurol 20:42-47
46. Markwalder TM, Gerber HA, Waelti E, Schaffner T, Markwalder RV (1988) Hormonotherapy of meningiomas with medroxyprogesterone acetate. Immunohistochemical demonstration of the effect of medroxyprogesterone acetate on growth fractions of meningioma cells using the monoclonal antibody Ki-67. Surg Neurol 30:97-101
47. Marosi C, Hassler M, Ssler R (2003) Guidelines to the treatment of meningioma. Forum (Genova) 13:76-89
48. Matsuda Y, Kawamoto K, Kiya K, Kurisu K, Sugiyama K, Uozumi T (1994) Antitumor effects of antiprogesterones on human meningioma cells in vitro and in vivo. J Neurosurg 80:527-534
49. Matsuno A, Fujimaki T, Sasaki T, Nagashima T, Ide T, Asai A, Matsuura R, Utsunomiya H, Kirino T (1996) Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas. Acta Neuropathol (Berl) 91:504-510
50. Maxwell M, Galanopoulos T, Neville-Golden J, Antoniades HN (1993) Expression of androgen and progesterone receptors in primary human meningiomas. J Neurosurg 78:456-462
51. Michelsen JJ, New PF (1969) Brain tumour and pregnancy. J Neurol Neurosurg Psychiatry 32:305-307
52. Nagashima G, Aoyagi M, Wakimoto H, Tamaki M, Ohno K, Hirakawa K (1995) Immunohistochemical detection of progesterone receptors and the correlation with Ki-67 labeling indices in paraffin-embedded sections of meningiomas. Neurosurgery 37:478-482
53. Olson JJ, Beck DW, Schlechte J, Loh PM (1986) Hormonal manipulation of meningiomas in vitro. J Neurosurg 65:99-107
54. Olson JJ, Beck DW, Schlechte JA, Loh PM (1987) Effect of the antiprogesterone RU-38486 on meningioma implanted into nude mice. J Neurosurg 66:584-587
55. Perrot-Applanat M, Groyer-Picard MT, Kujas M (1992) Immunocytochemical study of progesterone receptor in human meningioma. Acta Neurochir (Wien) 115:20-30
56. Perry A, Cai DX, Scheithauer BW, Swanson PE, Lohse CM, Newsham IF, Weaver A, Gutmann DH (2000) Merlin, DAL-1, and progesterone receptor expression in clinicopathologic subsets of meningioma: a correlative immunohistochemical study of 175 cases. J Neuropathol Exp Neurol 59:872-879
57. Piquer J, Cerda M, Lluch A, Barcia Salorio JL, Garcia-Conde J (1991) Correlations of female steroid hormone receptors with histologic features in meningiomas. Acta Neurochir (Wien) 110:38-43
58. Press MF, Greene GL (1988) Localization of progesterone receptor with monoclonal antibodies to the human progestin receptor. Endocrinology 122:1165-1175
59. Roser F, Samii M, Ostertag H, Bellinzona M (2004) The Ki-67 proliferating antigen in meningiomas. Experience in 600 cases. Acta Neurochir (Wien) 146:37-44
60. Schrell UM, Adams EF, Fahlbusch R, Greb R, Jirikowski G, Prior R, Ramalho-Ortigao FJ (1990) Hormonal dependency of cerebral meningiomas. Part 1. Female sex steroid receptors and their significance as specific markers for adjuvant medical therapy. J Neurosurg 73:743-749
61. Sharif S, Brennan P, Rawluk D (1998) Non-surgical treatment of meningioma: a case report and review. Br J Neurosurg 12:369-372
62. Simpson D (1957) The recurrence of intracranial meningiomas after surgical treatment. J Neurochem 20:22-39
63. Strik HM, Strobelt I, Pietsch-Breitfeld B, Iglesias-Rozas JR, Will B, Meyermann R (2002) The impact of progesterone receptor expression on relapse in the long-term clinical course of 93 benign meningiomas. In Vivo 16:265-270
64. Thom M, Martinian L (2002) Progesterone receptors are expressed with higher frequency by optic nerve sheath meningiomas. Clin Neuropathol 21:5-8
65. Verheijen FM, Sprong M, Jacobs HM, Donker GH, Amelink GJ, Thijssen JH, Blankenstein MA (2001) Progesterone receptor isoform expression in human meningiomas. Eur J Cancer 37:1488-1495
66. Verheijen FM, Donker GH, Viera CS, Sprang M, Jacobs HM, Blaauw G, Thijssen JH, Blankenstein MA (2002) Progesterone receptor, be 1-2 and bax expression in meningiomas. J Neurooncol 56:35-41